Nuclear ING2 expression is reduced in human cutaneous melanomas

British Journal of Cancer

Volumn 95, Issue 1, 2006, Pages 80-86

  Lu, F ^a   Dai, D L ^a   Martinka, M ^b   Ho, V ^a   Li, G ^a  

^a JACK BELL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Gene expression; ING2; Melanoma; Tissue microarray

Indexed keywords

ING2 PROTEIN; P33ING1B PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TISSUE MICROARRAY; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELL NUCLEUS; DYSPLASTIC NEVUS SYNDROME; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 33745578575     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603205     Document Type: Article

References (37)

1. Atallah E, Flaherty L (2005) Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 6: 185-193
2. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A (2001) Prognostic factors analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19: 3622-3634
3. Campos EI, Chin MY, Kuo WH, Li G (2004) Biological functions of the ING family tumour suppressors. Cell Mol Life Sci 61: 2597-2613
4. ING1 enhances UVB-induced apoptosis in melanoma cells. Exp Cell Res 279: 291-298
5. Cheung Jr KJ, Mitchell D, Lin P, Li G (2001) The tumour suppressor candidate p33 (ING1) mediates repair of UV-damaged DNA. Cancer Res 64: 4974-4977
6. Chin MY, Ng KC, Li G (2005) The novel tumour suppressor p33ING2 enhances UVB-induced apoptosis in human melanoma cells. Exp Cell Res 304: 531-543
7. Dai D, Makretsov N, Campos EI, Huang C, Zhou Y, Huntsman D, Martinka M, Li G (2003) Increased expression of integrin-linked kinase is correlated with melanoma progression. Clin Cancer Res 9: 4409-4414
8. Dai DL, Martinka M, Bush JA, Li G (2004) Reduced Apaf-1 expression in human cutaneous melanoma. Br J Cancer 91: 1089-1095
9. Dai DL, Martinka M, Li G (2005) Prognostic significance of activated Akt expression in melanoma: A clinicopathological study of 292 cases. J Clin Oncol 23: 1473-1482
10. Dunlap S, Yu X, Cheng L, Civin CI, Alani RM (2004) High-efficiency stable gene transduction in primary human melanocytes using a lentiviral expression system. J Invest Dermatol 122: 549-551
11. Elder D (1999) Tumour progression, early diagnosis and prognosis of melanoma. Acta Oncol 38: 535-547
12. Feng X, Hara Y, Riabowol K (2002) Different HATS of the ING1 gene family. Trends Cell Biol 12: 532-538
13. Fridman JS, Lowe SW (2003) Control of apoptosis by p53. Oncogene 22: 9030-9040
14. Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM, Gudkov AV (1998) The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 391: 295-298
15. Goel VK, Lazar AJ, Warneke CL, Redston MS, Haluska FG (2006) Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma. J Invest Dermatol 126: 154-160
16. Gozani O, Karuman P, Jones DR, Ivanov D, Cha J, Lugovskoy AA, Baird CL, Zhu H, Field SJ, Lessnick SL, Villasenor J, Mehrotra B, Chen J, Rao VR, Brugge JS, Ferguson CG, Payrastre B, Myszka DG, Cantley LC, Wagner G, Divecha N, Prestwich GD, Yuan J (2003) The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell 114: 99-111
17. Hussein MR (2004) The TP53 tumour suppressor gene and melanoma tumourigenesis: is there a relationship? Tumour Biol 25: 200-207
18. Karst AM, Dai DL, Martinka M, Li G (2005) PUMA expression is significantly reduced in human cutaneous melanomas. Oncogene 24: 1111-1116
19. Kameyama K, Huang CL, Liu D, Masuya D, Nakashima T, Sumitomo S, Takami Y, Kinoshita M, Yokomise H (2003) Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients. Clin Cancer Res 9: 4926-4934
20. Keller JM, Maize JC (1996) The clinical and histological differential diagnosis of malignant melanoma. Semin Oncol 23: 693-702
21. Li G, Tang L, Zhou X, Tron V, Ho V (1998) Chemotherapy-induced apoptosis in melanoma cells is p53 dependent. Melanoma Res 8: 17-23
22. Liston P, Pong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, Korneluk RG (2001) Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol 3: 128-133
23. Metcalf JS (1996) Melanoma: criteria for histological diagnosis and its reporting. Semin Oncol 23: 688-692
24. Nagashima M, Shiseki M, Miura K, Hagiwara K, Linke SP, Pedeux R, Wang XW, Yokota J, Riabowol K, Harris CC (2001) DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. Proc Natl Acad Sci USA 98: 9671-9676
25. Ng KP, Campos EI, Martinka M, Li G (2004) XAF1 expression is significantly reduced in human malignant melanoma. J Invest Dermatol 123: 1127-1134
26. Nouman GS, Anderson JJ, Wood KM, Lunec J, Hall AG, Reid MM, Angus B (2002) Loss of nuclear expression of the p33(ING1b) inhibitor of growth protein in childhood acute lymphoblastic leukaemia. J Clin Pathol 55: 596-601
27. Okano T, Gemma A, Hosoya Y, Hosomi Y, Nara M, Kokubo Y, Yoshimura A, Shibuya M, Nagashima M, Harris CC, Kudoh S (2006) Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Onco Rep 15: 545-549
28. Pedeux R, Sengupta S, Shen JC, Demidov ON, Saito S, Onogi H, Kumamoto K, Wincovitch S, Garfield SH, McMenamin M, Nagashima M, Grossman SR, Appella E, Harris CC (2005) ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. Mol Cell Biol 25: 6639-6648
29. Raffo AJ, Kim AL, Fine RL (2000) Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis. Oncogene 19: 6216-6228
30. Rigel DS (2002) The effect of sunscreen on melanoma risk. Dermatol Clin 20: 601-606
31. Sanchez-Carbayo M, Socci ND, Lozano JJ, Li W, Charytonowicz E, Belbin TJ, Prystowsky MB, Ortiz AR, Childs G, Cordon-Cardo C (2003) Gene discovery in bladder cancer progression using cDNA microarrays. Am J Pathol 163: 505-516
32. Schoenlaub P, Sarraux A, Grosshans E, Heid E, Cribier B (2001) Survival after cutaneous metastasis: a study of 200 cases. Ann Dermatol Venereol 128: 1310-1315
33. Shimada Y, Saito A, Suzuki M, Takahashi E, Horie M (1998) Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumour suppressor. Cytogenet Cell Genet 83: 232-235
34. Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279
35. Sironi E, Cerri A, Tomasini D, Sirchia SM, Porta G, Rossella F, Grati FR, Simoni G (2004) Loss of heterozygosity on chromosome 4q32-35 in sporadic basal cell carcinomas: evidence for the involvement of p33ING2/ING1L and SAP30 genes. J Cutan Pathol 31: 318-322
36. Toyama T, Iwase H, Watson P, Muzik H, Saettler E, Magliocco A, DiFrancesco L, Forsyth P, Garkavtsev I, Kobayashi S, Riabowol K (1999) Suppression of ING1 expression in sporadic breast cancer. Oncogene 18: 5187-5193
37. Wang J, Chin MY, Li G (2006) The novel tumour suppressor p33ING2 enhances nucleotide excision repair via inducement of histone H4 acetylation and chromatin relaxation. Cancer Res 66: 1906-1911